Rakesh M. Suri, MD, DPhil is a thought leader on innovative care models, along with international growth and transformation in pursuit of value. He served as the first President of International Operations at the Cleveland Clinic leading the overall international strategy and global business development efforts positioning the organization as One Cleveland Clinic in the United States and abroad.
From 2017-2021, Dr. Suri served as CEO at Cleveland Clinic Abu Dhabi. In this role, he oversaw the hospital’s strategy and effective operations as the first-ever U.S. multispecialty hospital to be replicated outside of North America with more than 6,000 caregivers from 85+ countries in partnership with stakeholder Mubadala, one of the world’s largest sovereign wealth funds.
As a leading cardiovascular surgeon, Dr. Suri added extensive and pioneering clinical expertise particularly in pre-emptive care for patients with asymptomatic mitral valve prolspe, robotic and minimally invasive mitral valve repair and transcatheter valve therapies and has completed more than 7,000 surgical procedures in his career.
Prior to that he was a consultant in the Division of Cardiovascular Surgery, Professor of Surgery and Chair of the Enterprise Robotic Practice at Mayo Clinic. His academic pursuits include contributions to more than 340 peer-reviewed journal articles and book chapters, more than 15 patents and several FDA multicenter trials. He was the Director of the Cardiovascular Fellowship Program at Mayo Clinic and past President of the Heart Valve Society.